Patient Centered Quality Care for Life Act
A BILL
To create a patient-centered quality of care initiative for seriously ill patients through the establishment of a stakeholder strategic summit, quality of life education and awareness initiative, health care workforce training, an advisory committee, and palliative care focused research, and for other purposes.
2. Findings
3. National patient-centered health care and quality of life stakeholder strategic summit
4. Quality of life patient and professional awareness grants program initiative
“W Programs Relating to Palliative Care
“399OO. Quality of life patient and professional awareness grants program initiative
“(a) In general—Not later than 6 months after the date of the submission of the report by the Patient-Centered Health Care and Quality of Life Stakeholder Strategic Summit under section 3(e) of the Patient Centered Quality Care for Life Act, the Secretary, through the Director of the Centers for Disease Control and Prevention, shall establish a national quality of life education and awareness grants program initiative for seriously ill patients, families of such patients, and health professionals who treat such patients for the purposes of encouraging an increased demand for and delivery of integrated and patient-centered care for managing pain and symptoms of such patients and improving the quality of life of such patients. Under the initiative, the Secretary shall, subject to subsection (h), award competitive grants to eligible entities described in subsection (b) to develop new and expand existing information, resources, and communication materials about symptom management and other aspects of patient-centered care as an integral part of quality care for serious illnesses such as cancer; heart, renal and liver failure; lung disease; and Alzheimer’s disease and related dementias. Such materials shall be presented in a variety of formats (such as online, print, and public service announcement).
“(b) Eligible entities—For purposes of this section, an eligible entity includes only a State health department, community health center, State or territory program supported by the National Comprehensive Cancer Control Program of the Centers for Disease Control and Prevention, health profession school, chronic disease or cancer center, academic medical center, physician practice, home health care agency, palliative care or psychosocial care team (as defined in subsection (g)), hospice program, patient non-profit organization (as defined in subsection (g)), clinical pastoral education program, long-term care facility, faith community organization, or other public or private entity or organization addressing patient-centered care and quality of life concerns of seriously ill patients.
“(c) Application—To be eligible to receive a grant under this section, an entity shall submit to the Secretary an application at such time, in such manner, and containing such information as the Director may require, including assurances that the entity will—
“(1) evaluate programs carried out by the entity through a grant provided under this section;
“(2) submit to the Secretary a report on the findings of such evaluations; and
“(3) coordinate the dissemination of such findings with the Secretary.
“(d) Use of funds—An entity awarded a grant under this section shall use such grant to carry out programs described in subsection (e), for patients and families of such patients that further the purposes described in subsection (a).
“(e) Programs—Programs described in this subsection, for which a grant awarded under this section may be used, include programs to—
“(1) navigate the health system, including assistance to patients with finding health professionals to support quality of life needs, care decision-making and coordination, and transitions across care settings;
“(2) provide general advocacy on behalf of patients and survivors to provide patients information to help them effectively communicate with health care providers about pain, physical and psychosocial symptoms, and barriers they are facing in adhering to curative or disease-directed treatments;
“(3) encourage health professionals to request coordinated patient-centered care consults for patients that are integrated alongside disease directed treatment in various care settings; and
“(4) collect and analyze data related to the effectiveness of the initiative under subsection (a).
“(f) Priority—In carrying out the grant program under this section, the Secretary shall give priority to applications that include an emphasis on addressing outreach efforts for seriously ill patients who are among medically underserved populations (as defined in section 1302(7)) and families of such patients or health professionals serving medically underserved populations. Such populations would include pediatric patients, young adult and adolescent patients, racial and ethnic minority populations, and other priority populations specified by the Secretary.
“(g) Definitions—For purposes of this section:
“(1) Psychosocial care team—The term psychosocial care team means health professionals focused on addressing social and emotional concerns of serious illness, and may include professionals such as social workers, psychiatrists, psychologists, nurses, child life specialists, teachers, chaplains, spiritual counselors, physical and occupational therapists, nutritionists, integrative medicine specialists, patient service coordinators, patient navigators, and patient representatives.
“(2) Patient non-profit organization—The term patient non-profit organization means a nonprofit entity primarily engaged in raising funds for health-related research, such as disease prevention, health education, and patient services.
“(h) Authorization of appropriations—There is authorized to be appropriated to carry out this section such sums as are necessary.”
5. Professional workforce training grants program initiative
“399OO–1. Professional workforce training grants program initiative
“(a) Initiative
“(1) In general—Not later than 6 months after the date of the submission of the report by the Patient-Centered Health Care and Quality of Life Stakeholder Strategic Summit under section 3(e) of the Patient Centered Quality Care for Life Act, the Secretary, through the Administrator of the Health Resources and Services Administration, shall establish a health care professional workforce training grants program initiative for the purposes of promoting and enhancing symptom assessment and management, communications skills, coordinated patient-centered care, and other quality of life focused clinical core competencies (as described in paragraph (2)) across all clinical specialties that serve seriously ill patients and patients with multiple or complex chronic diseases, such as patients with cancer; heart, renal, and liver failure; lung disease; and Alzheimer’s disease and related dementias. Under such initiative, the Secretary shall, subject to subsection (i), award competitive grants to eligible entities to provide evidence-based training and develop new training for health professionals, including physicians, nurses, social workers, and professional chaplains for the purposes described in the previous sentence.
“(2) Quality of life focused clinical core competencies described—For purposes of paragraph (1), quality of life focused clinical core competencies include, at a minimum, the assessment and management of physical, psychological, and spiritual symptoms; establishment of patient-centered goals of care; support to patient and family caregivers; and management of transitions across care sites.
“(b) Eligible entities—For purposes of subsection (a), an eligible entity is an entity described in section 399OO(b).
“(c) Application—To be eligible to receive a grant under this section, an entity shall submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require, including assurances that the entity will—
“(1) evaluate programs carried out by the entity through the grant provided under this section;
“(2) submit to the Secretary a report on the findings of such evaluations; and
“(3) coordinate the dissemination of such findings with the Secretary.
“(d) Use of funds—An entity awarded a grant under this section shall use such grant to carry out programs described in subsection (e) to train health care professionals described in subsection (a)(1) for the purposes described in such subsection.
“(e) Programs—Programs described in this subsection, for which a grant awarded under this section may be used, include programs to—
“(1) enhance health professional communication skills in caring for seriously ill patients and survivors, establishing goals of care, and tailoring treatments;
“(2) improve health profession identification of patient populations that benefit from coordinated palliative care and appropriate referral of patients for consultations with specialized interdisciplinary palliative care teams;
“(3) improve health professional skills in symptoms assessment and management, developing comprehensive care coordination and discharge plans to support transitions across care settings, managing patients with complex or multiple chronic conditions, and preparing survivorship care plans;
“(4) promote quality of life focused clinical core competencies (as described in subsection (a)(2)) across all clinical specialties serving seriously ill patients;
“(5) provide technical assistance to hospitals and other care settings to establish coordinated palliative care teams;
“(6) create and expand coordinated palliative care leadership centers (as defined in subsection (h));
“(7) provide mentoring and training to health professionals;
“(8) improve cultural sensitivity communication and patient care for minority and medically underserved populations, including by addressing the particular needs of children, adolescents, and families of such children and adolescents; racial and ethnic groups; and other medically underserved patient and survivor populations; and
“(9) collect and analyze data related to the effectiveness of health professional education and training efforts carried out pursuant to this section.
“(f) Priority—In carrying out the grant program under this section, the Secretary shall give priority to applications that include an emphasis on addressing outreach efforts for seriously ill patients who are among medically underserved populations (as defined in section 1302(7)) and families of such patients or health professionals serving medically underserved populations. Such populations would include pediatric patients, young adult and adolescent patients, racial and ethnic minority populations, and other priority populations specified by the Secretary.
“(g) Study—Not later than one year after the date of the enactment of the Patient Centered Quality Care for Life Act, the Secretary shall update and expand the September 2002 report of the Health Resources and Services Administration, titled “The Supply, Demand and Use of Palliative Care Physicians in the United States”. Such update and expansion shall be based on an examination of workforce trends, workforce capacity, and training needs for palliative medicine physicians, physician assistants, nurse practitioners, and other palliative care team members in all care settings in the United States, as well as training needs for other medical specialists and non-physician clinicians.
“(h) Palliative care leadership center defined—For purposes of this section, the term palliative care leadership center means a center—
“(1) that trains hospital palliative care programs;
“(2) that provides intensive operational training and mentoring for palliative care programs at every stage of development and growth; and
“(3) that provides training oriented to teams rather than individuals, and involves participation by teams of hospital and hospice health care professionals involved in starting or running a palliative care program, including physicians, nurses, social workers, administrators and financial managers.
“(i) Authorization of appropriations—There is authorized to be appropriated to carry out this section such sums as are necessary for each of the fiscal years 2014 through 2019.”
6. Quality of life cross-agency advisory committee
“399OO–2. Quality of life cross-agency advisory committee
“(a) Establishment—Not later than 90 days after the date of the enactment of this section and subject to subsection (e), the Secretary shall establish a Quality of Life Cross-Agency Advisory Committee (in this section to be referred to as the “Advisory Committee”) to advise, coordinate, and assist the Centers for Disease Control and Prevention and the Health Resources and Services Administration in creating and conducting the national quality of life education and awareness initiative under section 399OO and the health care professional workforce training initiative under section 399OO–1 and disseminate findings that have been identified from such initiatives for cross agency implementation of best practices.
“(b) Membership—The Advisory Committee shall be composed of members who shall be appointed by the Secretary and shall include representatives of—
“(1) the Department of Health and Human Services, including from the Centers for Disease Control and Prevention, the Health Resources and Services Administration, the Agency for Healthcare Research and Quality, the Centers for Medicare & Medicaid Services, and the National Institutes of Health;
“(2) the Department of Veterans Affairs;
“(3) the Department of Defense;
“(4) public and private organizations with expertise in patient-centered care, palliative care, psychosocial care, and symptom management and survivorship; and
“(5) such other representatives as the Secretary deems necessary.
“(c) Duties—The Advisory Committee shall—
“(1) evaluate the results of the programs funded by the grants awarded under section 399OO(b) and under section 399OO–1(b);
“(2) coordinate and implement a cross-agency strategic plan, with respect to the agencies specified in subsection (b), to disseminate findings from such programs;
“(3) advise the Secretary of Health and Human Services on strategies for disseminating across agencies specified in subsection (b) recommendations from the National Action Agenda described in section 3(c)(1) of the Patient Centered Quality Care for Life Act;
“(4) consider and summarize recent advances achieved in symptom management and survivorship research relevant to the goals of this part and make recommendations to the Director of the National Institutes of Health on gaps in basic, clinical, behavioral, or other research required to achieve further improvements in care to support quality of life and survivorship;
“(5) develop a strategy for developing new and enhancing health surveillance tools used to track symptoms, late effects, and quality care trends over time, including national surveys of the overall population of the United States, such as the National Health Interview Survey and the Behavioral Risk Factor Surveillance System conducted by the Centers for Disease Control and Prevention and the Health Information National Trends Survey conducted by the National Institutes of Health, as well as administrative databases and disease registries such as databases of the Centers for Medicare & Medicaid Services, the Surveillance Epidemiology and End Results (SEER) cancer registries program of the National Cancer Institute, the SEER–Medicare Linked Database of the National Cancer Institute, and the National Program of Cancer Registries of the Centers for Disease Control and Prevention; and
“(6) make appropriate updates and addendums annually to the National Action Agenda.
“(d) Meetings—The Advisory Committee shall meet at least once a year.
“(e) Authorization of appropriations—There are authorized to be appropriated to carry out this section such sums as are necessary for each of the fiscal years 2014 through 2019.”
7. Enhancing research in support of patient quality of life
“399OO–3. Enhancing research in support of patient quality of life
“(a) In general—The Secretary, acting through the Director of the National Institutes of Health, shall develop and implement a strategy to be applied across the institutes and centers of the National Institutes of Health that is in accordance with recommendations of the Advisory Committee established under section 399OO–2 to expand national research programs in symptom management, palliative, psychosocial, and survivorship care.
“(b) Research programs—The Director of the National Institutes of Health shall expand and intensify research programs in symptom management and palliative, psychosocial, and survivorship care and research programs that address the quality of life needs for the rapidly growing population in the United States of seriously ill patient (with illnesses such as cancer; heart, renal and live failure; lung disease; and Alzheimer’s disease and related dementias).”